1. Home
  2. FKWL vs TENX Comparison

FKWL vs TENX Comparison

Compare FKWL & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Wireless Corp.

FKWL

Franklin Wireless Corp.

HOLD

Current Price

$4.09

Market Cap

53.5M

Sector

Utilities

ML Signal

HOLD

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$12.80

Market Cap

56.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FKWL
TENX
Founded
1981
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.5M
56.2M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
FKWL
TENX
Price
$4.09
$12.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$6.00
$22.50
AVG Volume (30 Days)
8.0K
312.7K
Earning Date
02-13-2026
03-24-2026
Dividend Yield
0.97%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$45,508,949.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.49
N/A
P/E Ratio
N/A
N/A
Revenue Growth
32.05
N/A
52 Week Low
$3.67
$4.63
52 Week High
$7.45
$18.38

Technical Indicators

Market Signals
Indicator
FKWL
TENX
Relative Strength Index (RSI) 41.76 46.03
Support Level $4.05 $12.20
Resistance Level $4.19 $13.37
Average True Range (ATR) 0.05 1.00
MACD 0.00 -0.37
Stochastic Oscillator 28.57 11.75

Price Performance

Historical Comparison
FKWL
TENX

About FKWL Franklin Wireless Corp.

Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

Share on Social Networks: